Biotech Series C Investors & VC Firms
600 firms in this list, with a median first check of $1M. 112 of them lead rounds. Generated from verified public data and updated continuously.
Malaysia Debt Ventures Bhd.
Kuala LumpurSeed–Late Stage
2 people
Omron Ventures
KyotoSeed–Growth
2 people
Wild Basin Investments
TexasSeed–Growth
2 people
Ippon
GenevaSeries A–Growth
1 person
Astellas Venture Management
ChicagoSeed–Growth
1 person
Augere Venture
KrakówSeed–Late Stage
1 person
Ilshin Investment Co. Ltd.
SeoulSeed–Late Stage
1 person
INCJ, Ltd.
TokyoSeed–Late Stage
1 person
Nan Fung Life Sciences
Hong KongSeed–Growth
1 person
Shanghai STVC Group
ShanghaiSeed–Late Stage
1 person
Syngenta Group Ventures
ZurichSeed–Growth
1 person
Brandon Capital Partners
Seed–Growth
E-Crowd
Seed–Growth
JAIC
Palo AltoSeed–Late Stage
LDV Partners
Palo AltoPre-Seed–Late Stage
Santen Pharmaceutical
OsakaSeries A–Series C
Wellcome Trust
LondonSeed–Late Stage
3H Health Investment
ShanghaiSeries A–Late Stage
Avlar BioVentures
MadingleySeries A–Growth
Boehringer Ingelheim Venture Fund
Ingelheim am RheinSeed–Growth$16.2M
Candy Capital
Seed–Growth
Capital Medica Ventures
TokyoPre-Seed–Growth
CAS Star
Xi’anPre-Seed–Growth
CBC Group
SingaporeSeed–Late Stage
Related lists
Series C Investors & VC Firms (2751)Biotech Investors & VC Firms (2107)Biotech Seed Investors & VC Firms (1754)Biotech Series A Investors & VC Firms (1596)Biotech Investors & VC Firms in United States (1039)Series C Investors & VC Firms in United States (946)Biotech Series B Investors & VC Firms (900)Series C Investors & VC Firms in Global (896)Biotech Pre-Seed Investors & VC Firms (896)Healthtech Series C Investors & VC Firms (771)
Data sourced from public filings and firms' own websites — see our methodology.